Regresar
Mostrando 10 resultados de: 78
Filtros aplicados
Área temáticas
Enfermedades(55)
Fisiología humana(47)
Farmacología y terapéutica(27)
Ginecología, obstetricia, pediatría, geriatría(20)
Salud y seguridad personal(8)
11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen during Normal and Premature Adrenarche
ArticleAbstract: Context: Adrenarche refers to the rise of dehydroepiandrosterone sulfate (DHEA-S) associated with thPalabras claves:Autores:Auchus G.C., Kasa-Vubu J.Z., Lerario A.M., Rainey W.E., Rege J., Richard J. Auchus, Smith J.M., Turcu A.F., White P.C.Fuentes:scopus11-Oxygenated C19 Steroids Do Not Distinguish the Hyperandrogenic Phenotype of PCOS Daughters from Girls with Obesity
ArticleAbstract: Context: Hyperandrogenemia (HA) is a consistent reproductive phenotype in women with polycystic ovarPalabras claves:11-oxygenated C19 androgens, Hyperandrogenemia, obesity, Polycystic ovary syndromeAutores:Dunaif A., Legro R.S., Richard J. Auchus, Sisk R., Torchen L.C., Turcu A.F.Fuentes:scopus11-Oxygenated C<inf>19</inf> Steroids Do Not Decline with Age in Women
ArticleAbstract: The ovaries and adrenals are sources of androgens in women. Although dehydroepiandrosterone (DHEA),Palabras claves:Autores:Nanba A.T., Rainey W.E., Rege J., Ren J., Richard J. Auchus, Turcu A.F.Fuentes:scopus11-Oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency
ArticleAbstract: Context: Patients with 21-hydroxylase deficiency (21OHD) have long-term complications, resulting froPalabras claves:Autores:Avila N.A., Elman M.S., Mallappa A., Marko J., Merke D.P., Rao H., Richard J. Auchus, Tsodikov A., Turcu A.F.Fuentes:scopusA Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia
ArticleAbstract: Context: Patients with classic congenital adrenal hyperplasia (CAH) often require supraphysiologic gPalabras claves:adrenal hypertrophy, ATR-101, Clinical trial, Congenital adrenal hyperplasia, nevanimibeAutores:Chang A.Y., El-Maouche D., Joyal E.G., Lin V.H., Merke D.P., Mohideen P., Plaunt M.R., Richard J. Auchus, Turcu A.F., Vogiatzi M.G., Weintraub L.Fuentes:scopusA novel point mutation in P450c17 (CYP17) causing combined 17α-hydroxylase/17,20-lyase deficiency
ArticleAbstract: Context: Combined 17α-hydroxylase/17,20-lyase deficiency is a rare cause of congenital adrenal hyperPalabras claves:Autores:Achermann J.C., Ahmad T., Brooke A.M., Gore M.E., Lin L., Monson J.P., Papari-Zareei M., Richard J. Auchus, Rumsby G., Shepherd J.H., Taylor N.F.Fuentes:scopusA novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes
ArticleAbstract: Design, Setting, and Participants: Genomic DNA samples (15 affected and 26 unaffected from a six-genPalabras claves:Autores:Andres Zurita, Andrew S., Carolina Guevara, Dauber A., Geng J., Guo M., Hwa V., Jaime Guevara-Aguirre, Kerns S.L., Marco Guevara-Aguirre, Oddoux C., Ostrer H., Rosenfeld R.G., Shen Y.Fuentes:scopusA randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency
ArticleAbstract: GH insensitivity due to GH receptor deficiency is a rare autosomal recessive condition, characterizePalabras claves:Autores:Diamond F.B., Gargosky S.E., Jaime Guevara-Aguirre, Martinez L., Martinez V., Nonoshita L., Rosenbloom A.L., Rosenfeld R.G., Vasconez O.Fuentes:scopusClamping Cortisol and Testosterone Mitigates the Development of Insulin Resistance during Sleep Restriction in Men
ArticleAbstract: Context: Sleep loss in men increases cortisol and decreases testosterone, and sleep restriction by 3Palabras claves:cytokines, dual hormone clamp, hyperglycemia, hyperinsulinemia, Insulin Resistance, sleep lossAutores:Iranmanesh A., Lawrence-Sidebottom D., Liu P.Y., Piotrowska K., Richard J. Auchus, Van Dongen H.P.A., Veldhuis J.D., Zhang W.Fuentes:scopusClinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer
ArticleAbstract: Context: Abiraterone acetate is a small-molecule cytochrome P450 17A1 (CYP17A1) inhibitor that is acPalabras claves:Autores:Arlt W., Attard G., Cassidy A.M., De Bono J.S., Dowsett M., Folkerd E., Hughes B.A., Oommen N.B., Reid A.H.M., Richard J. Auchus, Thompson E.Fuentes:scopus